| Market Cap | ₹42Cr |
| ROE | 3.69% |
| P/E Ratio(TTM) | 27.31 |
| EPS(TTM) | 1.61 |
| P/B Ratio | 1.27 |
| Dividend Yield | 1.82% |
| Industry P/E | 34.73 |
| Book Value | 34.63 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Sandu Pharmaceuticals Limited |
| Managing Director | Shri. Umesh Sandu |
| BSE Symbol | 524703 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |